Earnings · China A-shares
Lushang Freda Pharmaceutical Co., Ltd. Class A (600223) earnings
Lushang Freda Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -21.66% year on year, -18.81% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -3.86% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -21.66%
- Excl. one-offs YoY
- -18.81%
- Net profit QoQ
- -41.36%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.92% | — |
| 3 days | -3.86% | — |
| 7 days | -0.18% | — |
| 14 days | -2.94% | — |
Report history
Over the last 8 reports, net profit grew year on year in 0 of them. The stock rose in the 3 trading days after 1 of 8 reports (average -1.67%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥111.04M | -21.66% | -18.81% | +6.84% | 0.11 | 2.59% | -3.86% | — | — |
| 2026 interim report | 2026-08-26 | ¥81.78M | -24.25% | -26.77% | +6.69% | 0.08 | 1.91% | -0.52% | -1.04% | +5.96% |
| 2026 Q1 report | 2026-04-28 | ¥31.90M | -37.10% | -36.30% | +2.78% | 0.03 | 0.75% | -3.53% | -18.41% | -17.79% |
| 2025 annual report | 2026-04-03 | ¥187.75M | -22.90% | -19.30% | -8.33% | 0.18 | 4.50% | -0.86% | -11.03% | -19.61% |
| 2025 Q3 report | 2025-10-28 | ¥141.74M | -17.19% | -13.70% | -7.34% | 0.14 | 3.42% | -2.54% | -5.22% | -1.84% |
| 2025 interim report | 2025-08-22 | ¥107.96M | -15.16% | -6.25% | -7.05% | 0.11 | 2.60% | -0.70% | -9.22% | -17.01% |
| 2025 Q1 report | 2025-04-25 | ¥50.71M | -14.10% | -9.67% | -1.63% | 0.05 | 1.23% | -4.88% | +19.38% | +16.14% |
| 2024 annual report | 2025-03-22 | ¥243.53M | -19.73% | +54.54% | -13.02% | 0.24 | 5.85% | +3.52% | +0.27% | +3.29% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.